Diagnos (TSE:ADK) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Diagnos Inc., an AI tech firm, completed a private placement raising $2.5 million by selling units at $0.30 each, including shares and warrants. The funds will advance AI-based health screening services and support general operations. The warrants allow purchasing additional shares at $0.40 until March 2026.
For further insights into TSE:ADK stock, check out TipRanks’ Stock Analysis page.